{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:40:54Z","timestamp":1788799254587,"version":"build-2803163510"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Sildenafil citrate is a highly effective erectogenic agent. However, predicting which patients will respond to this agent is often difficult. While the patient response to this agent is dependent on the nitric oxide\u2013guanylate cyclase\u2013cyclic guanosine monophosphate cascade, the integrity of penile arterial flow and venocclusive mechanism is also important. Duplex Doppler penile ultrasonography can reliably document penile hemodynamics. This study aimed at defining response rates based on degree of penile vascular sufficiency.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study enrolled patients who met strict criteria for sildenafil citrate response who had also undergone penile ultrasound. Correlation was drawn between the nature and the severity of the vascular insufficiency and the response rate to sildenafil citrate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The distribution of vascular diagnoses was arteriogenic 64%, venogenic 6%, mixed vascular insufficiency 18%, and normal 12%. The best response was seen in those men with normal vascular studies, 80% responding. Fifty-three percent of all men with any abnormality on penile ultrasound responded; 65% of men with arteriogenic erectile dysfunction (ED), 25% of patients with venogenic ED, and 6% of men with a mixed vascular insufficiency were responders. There was a correlation between the degree of vascular impairment and the response rate. All men with venogenic ED who responded had mild leak.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These data demonstrate a correlation between the nature and severity of penile vascular disease and the ability to respond to sildenafil citrate. These data may be useful to the sexual medicine practitioner when counseling patients regarding oral erectogenic therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2005.20110.x","type":"journal-article","created":{"date-parts":[[2005,1,8]],"date-time":"2005-01-08T21:06:21Z","timestamp":1105218381000},"page":"104-108","source":"Crossref","is-referenced-by-count":26,"title":["Sildenafil Citrate Response Correlates with the Nature and the Severity of Penile Vascular Insufficiency"],"prefix":"10.1093","volume":"2","author":[{"given":"John","family":"Mulhall","sequence":"first","affiliation":[{"name":"Weill Medical College of Cornell University\u2014Department of Urology , New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Barnas","sequence":"additional","affiliation":[{"name":"Weill Medical College of Cornell University\u2014Department of Urology , New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadid","family":"Aviv","sequence":"additional","affiliation":[{"name":"Department of Urology, Loyola University Medical Center , Maywood , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Urology, Loyola University Medical Center , Maywood , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Urology, Loyola University Medical Center , Maywood , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,1,1]]},"reference":[{"key":"2024032600071952200_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jama.1993.03510010089036","article-title":"Impotence. NIH Consensus Development Panel on Impotence","volume":"270","author":"NIH Consensus Conference.","year":"1993","journal-title":"JAMA"},{"key":"2024032600071952200_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral Sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2024032600071952200_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0094-0143(05)70141-5","article-title":"Oral drug therapy for erectile dysfunction","volume":"28","author":"Padma-Nathan","year":"2001","journal-title":"Urol Clin North Am"},{"key":"2024032600071952200_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1742-1241.2001.tb10992.x","article-title":"Three-year update of sildenafil citrate (Viagra) efficacy and safety","volume":"55","author":"Sadovsky","year":"2001","journal-title":"Int J Clin Pract"},{"key":"2024032600071952200_bib5","first-page":"S625","article-title":"Current concepts in erectile dysfunction","volume":"6","author":"Mulhall","year":"2000","journal-title":"Am J Manag Care"},{"key":"2024032600071952200_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1742-1241.2001.tb11009.x","article-title":"Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease","volume":"55","author":"Olsson","year":"2001","journal-title":"Int J Clin Pract"},{"key":"2024032600071952200_bib7","first-page":"233","article-title":"Topical and oral agents for erectile dysfunction","volume":"98","author":"Lue","year":"1999","journal-title":"J Formos Med Assoc"},{"key":"2024032600071952200_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0090-4295(01)00984-0","article-title":"Efficacy, safety, and use of sildenafil in urologic practice","volume":"57","author":"Fagelman","year":"2001","journal-title":"Urology"},{"key":"2024032600071952200_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.178.4.325","article-title":"Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction","volume":"178","author":"Eardley","year":"2001","journal-title":"Br J Psychiatry"},{"key":"2024032600071952200_bib10","doi-asserted-by":"crossref","first-page":"29C","DOI":"10.1016\/S0002-9149(99)00045-4","article-title":"Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction with ischemic heart disease","volume":"83","author":"Conti","year":"1999","journal-title":"Am J Cardiol"},{"key":"2024032600071952200_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(02)01691-6","article-title":"Depression, antidepressant therapies and erectile dysfunction: Clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression","volume":"60","author":"Nurnberg","year":"2002","journal-title":"Urology"},{"key":"2024032600071952200_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","article-title":"Sildenafil for treatment of erectile dysfunction in men with diabetes","volume":"281","author":"Rendell","year":"1999","journal-title":"JAMA"},{"key":"2024032600071952200_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0090-4295(99)00441-0","article-title":"Role of viagra after radical prostatectomy","volume":"55","author":"Zippe","year":"2000","journal-title":"Urology"},{"key":"2024032600071952200_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0090-4295(98)00582-2","article-title":"Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction (EDITS)","volume":"53","author":"Althof","year":"1999","journal-title":"Urology"},{"key":"2024032600071952200_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile function","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"2024032600071952200_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0037-198X(05)80112-9","article-title":"Duplex Doppler ultrasonography: Noninvasive assessment of penile anatomy and function","volume":"28","author":"Broderick","year":"1993","journal-title":"Seminars Roentgenol"},{"key":"2024032600071952200_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2214\/ajr.153.6.1141","article-title":"Duplex and color Doppler sonographic evaluation of vasculogenic impotence","volume":"153","author":"Quam","year":"1989","journal-title":"AJR Am J Roentgenol"},{"key":"2024032600071952200_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-5347(05)65865-X","article-title":"Improving the accuracy of vascular testing of the impotent male: Correction of hemodynamic alterations using a vasoactive medication redosing schedule","volume":"166","author":"Mulhall","year":"2001","journal-title":"J Urol"},{"key":"2024032600071952200_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000019583","article-title":"The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity","volume":"33","author":"De Meyer","year":"1998","journal-title":"Eur Urol"},{"key":"2024032600071952200_bib20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1002\/j.1939-4640.2002.tb02292.x","article-title":"Nitric oxide regulation of penile erection: Biology and therapeutic implications","volume":"23","author":"Burnett","year":"2002","journal-title":"J Androl"},{"key":"2024032600071952200_bib21","first-page":"129","article-title":"Intracavernosal injection therapy: A practical guide","volume":"3","author":"Mulhall","year":"1997","journal-title":"Tech Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515311334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515311334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/2\/1\/104\/47522299\/jsm_2_1_104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/2\/1\/104\/47522299\/jsm_2_1_104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:04:34Z","timestamp":1711415074000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/2\/1\/104\/6863019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1,1]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2005.20110.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2005,1,1]]}}}